Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111702) titled 'Prophylactic Antibiotics in Groin Hernioplasty' on Aug. 1.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Sana'a University
Condition:
Surgical Site Infection
Groin Hernia
Hernioplasty
Intervention:
Drug: Cefazolin
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 1, 2023
Target Sample Size: 100
Countries of Recruitment:
Yemen
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07111702
Published by HT Digital Content Services wi...